George A. Papandreou served as Greece’s Prime minister on the outbreak of the Greek financial crisis, managing to avoid his country’s bankruptcy, whilst applying a series of structural reforms for modernizing his country. In 2010 he was awarded Germany’s Quadriga Award in the category “Power of Veracity”, for his achievements related to government Transparency. For his efforts to reform Greece, he was named one of the Foreign Policy magazine’s TOP 100 Global Thinkers in 2010.
As an MP (1981-2015), he served in several government posts, as undersecretary of Culture and Minister of Education, before becoming Foreign Minister from 1999-2004. In 1997, as Foreign Minister, George Papandreou in collaboration with his Turkish counterpart, late Ismail Cem, achieved a breakthrough in Greek - Turkish relations, initiating a gradual rapprochement following the Imia crisis that brought the two countries almost at the edge of a war. He also played a key role in the negotiations that led to Turkey's EU candidacy in 1999 and Cyprus's entry in the European Union in 2004.
As Minister of Education, he founded the Greek Open University, which allowed for all to participate in distance studies for University degrees, he established multi-cultural schools, and instituted a minimum quota for students in Greek universities who were members of the Muslim community in Greece.
Currently he is the President of the Socialist International (SI). The SI has a consultative status - Category I - with the United Nations.
He is also the co-chair of the Democratic Alignment, a coalition of the center left parties in Greece, composed by the Panhellenic Socialist Movement (PASOK), the Democratic Left (DIMAR) and the Movement of Democratic Socialists.
RECENT - CURRENT INTERNATIONAL ACTIVITY
Mr. Jerry Liao is the CEO and founder of WeDoctor Group (formerly Guahao.com), a leading healthcare solutions platform using technology and Artificial Intelligence to provide quality and accessible healthcare services for everyone. WeDoctor has three core business including technology enabled healthcare solutions platform, offline healthcare services and healthcare financial services. As of today, WeDoctor has connected over 2,400 hospitals, more than 120 million platform users and over 220,000 doctors across China.
Before founding WeDoctor, Mr. Liao served as head of the Intelligent Computer Technology Commercialization Base (National 863 Program) for a long time. He was one of the early founders of iFlytek Co., an A-share listed company with market value over RMB 90 billion and holds several invention patents on intelligent voice recognition technology. Forbes ranked him among the "Top 10 Innovative Entrepreneurs in China and the United States” in September 2015. He also won “Internet & Health Most Influential Figure of Year 2015”, “Top Ten Influential Internet Figure of Year 2015 for Zhejiang Province”, “2016 Figures of Service Innovation of China”, “2016 Top Ten Maker of China” and “2017 Honorable Founder of Tencent Ecosystem Entrepreneurs”
He has also held various social positions, some of which include:
Peter Piot MD PhD is the Director of the London School of Hygiene & Tropical Medicine, and the Handa Professor of Global Health. He was the founding Executive Director of UNAIDS and Under Secretary-General of the United Nations (1995-2008). He is the Chair of the HMG Strategic Coherence of ODA Funded Research Board
A clinician and microbiologist by training, he co-discovered the Ebola virus in Zaire in 1976, and subsequently led pioneering research on HIV/AIDS, women’s health and infectious diseases in Africa. He has held academic positions at the Institute of Tropical Medicine, Antwerp; the University of Nairobi; the University of Washington, Seattle; Imperial College London, and the College de France, Paris, and was a Senior Fellow at the Bill & Melinda Gates Foundation. He is a member of the US National Academy of Medicine, the National Academy of Medicine of France, the Royal Academy of Medicine of his native Belgium, the National Academy of Sciences Leopoldina of Germany and is a fellow of the UK Academy of Medical Sciences and the Royal College of Physicians.
He is a past president of the International AIDS Society and of the King Baudouin Foundation. In 1995 he was made a baron by King Albert II of Belgium, and in 2016 was awarded an honorary knighthood KCMG.
Professor Piot has received numerous awards for his research and service, including the Canada Gairdner Global Health Award (2015), the Robert Koch Gold Medal (2015), the Prince Mahidol Award for Public Health (2014), and the Hideyo Noguchi Africa Prize for Medical Research (2013), the F.Calderone Medal (2003), and was named a 2014 TIME Person of the Year (The Ebola Fighters). He has published over 580 scientific articles and 16 books, including his memoir, No Time to Lose.
Ashish Jha, MD, MPH, is the Senior Associate Dean for Research Translation and Global Strategy and K.T. Li Professor of Global Health at the Harvard T.H. Chan School of Public Health and the Director of the Harvard Global Health Institute. He is also a practicing General Internist at the VA Boston Healthcare System and Professor of Medicine at Harvard Medical School.
Dr. Jha received his MD from Harvard Medical School and then trained in Internal Medicine at the University of California in San Francisco. He completed his General Medicine fellowship at Brigham & Women’s Hospital at Harvard Medical School and received his MPH from the Harvard T.H. Chan School of Public Health. His research endeavors focus on improving the quality and costs of health care systems with a specialized focus on the impact of policies. Dr. Jha has published over two hundred empirical papers and writes regularly about ways to improve health care systems, both in the U.S. and globally. Dr. Jha was elected as a member of the National Academy of Medicine in 2013.
For ten years, Robyn has led a food awakening among consumers, corporations and political leaders. Her focus is on restoring the health of American families in order to address the burden that disease in placing on our economy. All of her initiatives and work address the needs of the 1 in 3 American children that now has allergies, autism, ADHD and asthma and the growing number of American children with cancer.
Armed with data and analytics, food companies now responding to Robyn’s work include Bloomberg, Compass Food Group, Kraft, Coca Cola, Burger King, Chipotle, Nestle, Target and others. She sheds light on how the changing landscape of food and health are impacting the food industry and our economy.
She leads a non-profit and an advisory firm and is a best-selling author, public speaker, strategist and mother of four. She brings insight and detailed analysis to her research on the health of the American food system as documented in her first book, The Unhealthy Truth, and has been called “food’s Erin Brockovich” by Bloomberg and the New York Times.
Her work has appeared on CNN, CNBC, Bloomberg, the Today Show, Good Morning America, FOX News, in the Washington Post and countless media outlets, and she wrote a very popular column for Prevention called Inspired Bites while serving as the Executive Director of the AllergyKids Foundation and doing strategic advisory work for companies making trend-setting changes in the food industry.
Robyn has been named by SHAPE Magazine as a “Women To Shape the World,” by Forbes Woman as one of “20 Inspiring Women to Follow on Twitter,” and by The Discovery Channel as one of its 15 Top Visionaries. Her TEDx talks have been widely received, and she recently spoke at Tony Robbins’ financial conference, addressing “The New Food Economy.”
She serves on the Board of Directors of Healthy Child Healthy World and other non-profit organizations. She also serves on advisory boards for start-ups and has been hired to speak at Target, Compass Food Group, Bloomberg and to both organic and multinational food companies. She is constructive and solution-oriented, recognizing that solutions must address shareholders and stakeholders concerns if they are to be true solutions. Named after a farmer, she also is focused on supply chain issue and the financial structure of the farming system.
Robert C. Green, MD, MPH is a medical geneticist and physician-scientist who directs the G2P Research Program (genomes2people.org) in translational genomics and health outcomes as Professor of Medicine in the Division of Genetics at Brigham and Women’s Hospital, the Broad Institute and Harvard Medical School. Dr. Green has been continuously funded by NIH for 26 years and has published over 300 papers. Originally trained as a neurologist and epidemiologist, he contributed for over a decade to the clinical characterization, treatment trial methodology and risk refinement for Alzheimer’s disease. After re-training as a medical geneticist, he conducts empirical research on the medical, behavioral and economic outcomes around the implementation of genomic medicine. Dr. Green led the first NIH-funded trials disclosing common complex disease risk (REVEAL Study) and the first prospective study of direct-to-consumer genetic testing (PGen Study). He currently leads and co-leads the first randomized trials to explore the implementation of medical sequencing in adults (MedSeq Project) and newborns (BabySeq Project). His team recently published the MedSeq Project results assessing medical outcomes, appropriateness of care and downstream medical costs of whole genome sequencing in primary care. With support from the Air Force, and in collaboration with military medicine colleagues, he is conducting the first implementation study of sequencing with return of results in active duty military personnel (MilSeq Project). Dr. Green was lead author on the original recommendations for managing secondary findings in clinical sequencing from the American College of Medical Genetics and Genomics and led the first published demonstration of aggregate penetrance of genomic variants in an unselected population. He is a member of the National Academies of Science, Engineering and Medicine Committee on the “Evidence Base for Genetic Testing” and a Board Member of the Council for Responsible Genetics. He works with the Global Alliance for Genome Health and with the All of Us Research Program on implementation standards for communicating genomic information. In 2014, he won the Coriell Prize for Scientific Achievement in Personalized Medicine.
Popularly known as “Dr. Mao”, Dr. Mao Shing Ni first began his studies in Chinese medicine with his father, Hua-Ching Ni, a renowned physician, Taoist master and author-teacher. After earning his doctorate and Ph.D. in Oriental Medicine with an emphasis in Nutrition Dr. Mao completed his postgraduate residency at Zhongshan Hospital/Shanghai Medical University in China. He began his medical career studying centenarians, first in China and then around the world. A bestselling author, expert on longevity medicine, co-founder, past president and current chairman of the Board of Trustees of Yo San University, Dr. Mao was born and raised in a family medical tradition that has spanned 38 generations. Recipient of the Acupuncturist of the Year award and The Best of the Best award on The Doctor Oz Show, Dr. Mao has appeared extensively in national media in his tireless efforts to further the recognition of acupuncture and Chinese medicine. He maintains a full-time clinical practice with his team of associates at the Tao of Wellness with offices throughout southern California. Among his eighteen publications is respected translation of the Yellow Emperor’s Classic of Medicine and The Tao of Nutrition, which still serves as a required text for the California State Board Examination. He is the author of the bestseller Secrets of Longevity, translated into 22 languages and the upcoming book, Cancer: an integrative approach to the care and prevention with nutrition, Chinese medicine and mind-body practices (October, 2018)
Dr. Suhas Kshirsagar is a world-renown Ayurvedic physician & Educator from India born of a traditional Rig-Vedic family. He holds a M.D. in Ayurvedic Medicine, with a Gold Medal from the prestigious Pune University in India.
Dr. Suhas is one of the most academically accomplished Ayurvedic physicians in US, who has traveled worldwide popularizing Ayurvedic Medicine, setting up clinics, offering courses for both medical professional and laypersons, and has provided Ayurvedic consultations for thousands of patients.
He is an internationally acclaimed motivational speaker and a visiting Professor at various Ayurvedic Schools & Universities, worldwide. He is an Adviser and Consultant for the Chopra Center. He was featured in numerous radio and television shows like Dr OZ, NBC and many more. He is an experienced Clinician & an insightful Vedic Counselor, who adds tremendous value to his clients and students alike.
He is an internationally acclaimed Researcher, Best Selling Author, Formulator and Consultant to various nutraceutical companies.
He is the lead formulator of Zrii, Achieve, Accell, Zrii Rise & Purify.
He is currently the Director of "Ayurvedic Healing" an Integrative Wellness Clinic in Santa Cruz, California.
Marc Koska OBE is the inventor of the K1 Auto-Disable syringe, the founder of Safepoint Trust (a UK-registered charity) and a highly regarded advocate around the world for needle safety in both immunisation and therapeutic sectors. His mission in life is the mandatory use of auto-disable syringes globally, to reduce cross-infection through dirty needles and needle-stick injuries, the world’s ninth biggest killer annually.
He has created successful behavioral change / public safety campaigns – for example in India, where in 2008 Safepoint Trust created one of the largest ever public health campaigns in India, leading to mandatory use of auto-disable syringes in all governmental and subsequently all private hospitals. Marc and the SafePoint Trust have catapulted safe injections to the top of the international health agenda, as on 23 February 2015, Margaret Chan, DG WHO announced a new global policy on injection safety.
More recently Marc has been working on The ApiJect System – which is a step into the future for vaccine packaging and delivery. It will improve injections - actually revolutionise them - way past the point anyone had thought of up to now. ApiJect are new devices, which do deliver injections, but are better in many ways ranging from manufacturing costs to range of delivery to environmental benefits. The System provides a more economic and robust delivery system with features that add considerable functionality. It is also a catalyst for a new generation of drug delivery, which will change availability and reliability forever.
Colin Milner is CEO of the International Council on Active Aging and founder of the active-aging industry in North America. Milner is also a leading authority on the health and well-being of the older adult, and has been recognized by the World Economic Forum as one of "the most innovative and influential minds" in the world on aging-related topics.
An award-winning writer, Milner has authored more than 300 articles. He has been published in such journals as Global Policy, and the Annual Review of Gerontology and Geriatrics. He also contributed a chapter to the World Economic Forum book Global Population Ageing: Peril or Promise?
Milner's speeches have stimulated thousands of business and government leaders, industry professionals & older adults worldwide.
Whether Fortune 500 companies, or governmental organizations, Milner's efforts have inspired a broad spectrum of groups to seek his counsel, include amongst these:
Meena is one of India’s foremost business leaders and most successful entrepreneurs with nearly three decades of experience in industries including healthcare, consulting, technology, outsourcing, education and e-commerce.
As the MD & CEO, Meena heads Portea Medical (www.portea.com), India’s leading consumer healthcare brand that operates across four major segments: primary care, chronic disease management, elder care and post-operative care. Services offered include physiotherapy, doctor consultations, new mother-and-baby care, specialty pharmacy, nutritional wellness, diabetic care, surgery discovery and tele-consultation. Portea works with more than 50 leading hospital partners, 15 pharma majors and leading insurance companies in India.
The company, which was named ‘Startup of the Year’ by NDTV in the Health-Tech category, and ‘Emerging Health Brand of the Year’ at the India Health Summit & Awards, has 4500+ employees and operations across 16 cities in India. Portea’s investors include Accel, International Finance Corporation (IFC), a member of the World Bank Group, Qualcomm Ventures, Ventureast, Sabre Partners and MEMG-CDC.
Till February 2013, Meena was a promoter and board member of TutorVista, and CEO and MD of Pearson Education Services, which included innovative and successful brands such as leading online tutoring company, TutorVista, and Edurite, a provider of technology-based solutions and digital content. TutorVista was acquired by Pearson, the world’s top education services company, for $ 213 MM in what was one of the largest deals in the Indian education sector.
As a partner of the platform, Growthstory.in, she is also co-promoter of nearly a dozen, new-age Internet/ Technology enabled start-ups. A few of them that are leaders in their category include Bigbasket.com - India’s premier e-grocery retailer, home solutions company - HomeLane, food tech company, FreshMenu and Bluestone.com – India’s leading online jeweler. In addition, she is a non-executive director on the board of a few other private limited companies in the financial services sector.
Prior to her stint with Pearson, Meena set up the Tesco Hindustan Service Center, Tesco’s outsourced IT services and analytics operation in India, and served as the CEO. She was also the only Indian and amongst only four women in the Global Retail Council of Tesco, an elite group of about 50 people who ran the operations of Tesco worldwide.
Before joining Tesco‚ Meena co-founded one of India’s pioneering BPO companies - Customer Asset, which she sold to ICICI OneSource. She was the Chief Operating Officer of Customer Asset and helped build the organization to nearly 4,000 people‚ servicing large corporate customers in UK and US markets.
Meena also had a five year stint with Microsoft India‚ during which she set up multiple business units including Microsoft Consulting‚ Internet and Application Development/Business services units. During the initial 11 years of her career, Meena was with PricewaterhouseCoopers and with NIIT.
Meena is a PGDM holder from IIM Calcutta has a graduate degree in Physics from the Madras University. In 2011, she was conferred the ‘Distinguished Alumnus’ award by IIM Calcutta.
In 2015, Meena was among the 7-member jury for the inaugural Economic Times Startup Awards. She won the ET Startup Award in the Women Ahead category in 2016 and was chosen as Health Entrepreneur of the Year (2016) at the India Health Summit & Awards. Meena has been part of Fortune India’s 50 'Most Powerful Women in Business' for three consecutive years (2015 - 2017), and was chosen a #WPower Trailblazer by Forbes India in 2017.
Meena serves on the Board of Governors of the Indian Institute of Management-Calcutta. She is also a member of the CII (Confederation of Indian Industry) Innovation & Entrepreneurship Council as well as of the CII Healthcare Council.
Dr. Catherine Mohr is a HealthTech executive with over 20 years of experience in the areas of strategy, research, product development, and organizational change. She is currently the Vice President of Strategy at Intuitive Surgical, a high technology surgical robotics company that makes the da Vinci Surgical System. In this role she evaluates new technologies for incorporation into the next generation of computer aided surgical platforms, and studies the dynamics of emerging markets. In addition, she is on Faculty at Singularity University which studies the impact of exponentially changing technologies on our society.
Catherine has a diverse background which covers surgery, medical technology, engineering, product design, healthcare, alternative energy, automotive, aerospace, global entrepreneurship, IP litigation, FDA compliance, education, and product development. From this she brings extensive industry experience and deep insights into emerging opportunities, trends, issues and challenges. Proven history of visionary thought-leadership as an advisor on future technologies to a wide range of companies and government agencies, and a sought-after speaker/lecturer.
Dr. Mohr received her BS and MS in mechanical engineering from MIT, and her MD from Stanford University School of Medicine. She has been involved with numerous startup companies in the areas of alternative energy transportation, and worked for many years developing high altitude aircraft and high efficiency fuel cell power systems, computer aided design software, and medical devices.
Dr Mohr has served as a scientific advisor for several startup companies in Silicon Valley, the NCI SBIR program, and government technology development programs in her native New Zealand, and entrepreneurship programs worldwide. She is the author of numerous scientific publications, the recipient of multiple design awards, and speaks regularly internationally on the subject of the future of surgery, technology and robotics.
John Petrovich is the President and CEO of The Alfred Mann Foundation for Scientific Research (AMF), a non-profit organization founded by the healthcare legend, Alfred E Mann. AMF was established in 1985 with the mission to bring advanced technologies to patients with unmet or poorly met medical needs. AMF’s world class team of engineers, software designers, and clinical specialists have created novel, groundbreaking medical technologies that have had great impact on the lives of thousands of people. Developments include a system to reanimate paralyzed limbs, low cost diagnostic systems, drug delivery devices, controls systems for advanced prosthetic devices and implantable neuromodulation devices to treat nerve pain.
John is an accomplished entrepreneur who started his career in law, spending two decades practicing corporate finance/merger & acquisition law. He has been the co-founder, President and CEO of two startup pharmaceutical companies, Calando Pharmaceuticals and Insert Therapeutics, where he successfully completed two licensing collaborations and raised four rounds of venture capital.
In between legal and entrepreneurial engagements, he has carried on a legal consulting practice offering strategic, tactical, legal and business advice and guidance to startups and early-stage companies in all sectors, with a special emphasis in the life sciences and entertainment/media/marketing development companies. The emphasis was on business formation, contract drafting and negotiation, licensing. He successfully licensed to Pfizer Pharmaceuticals an anti-cancer antibody on behalf of biotech client launched out of UCLA.
Mr. Petrovich received his BS in Business administration from the University of Southern California and earned his Juris Doctor from UCLA.
In 1982, Gurpreet ‘Sunny’ Singh was a freshman at India’s coveted engineering institution very own Ivy-League school, the Indian Institute of Technology (IIT). Little did he know that he was going to go on to become the founder of a $100m company named Edifecs. And also, become a major industry disruptor by building RoundGlass, a global firm dedicated to accelerating the future of digital health and wellness solutions and improving the lives of people.
Singh’s humble journey is marked by key milestones, ranging from his Dual Master’s Degree from Montana State University in Industrial Engineering and Computer Science to stepping in as software and industrial engineering expert for Expeditors International and Microsoft.
While working with these global tech-giants, he realized the need for a solution that fixes the data-management problems that plagued the industry. Edifecs is Singh’s blueprint of that solution. In 1996, Singh set up the company with the sole purpose of developing processes that increase the accuracy of tracking and processing monumental quantities of data. 20 years later, Edifecs is an industry leader that provides a comprehensive set of integrated solutions for the global healthcare ecosystem. The company is dedicated to improving clinical outcomes, maintaining cost reductions and accelerating innovation to improve healthcare outcomes.
Through sheer hard work and unquantifiable amount of determination, Singh has turned Edifecs into a global success. The firm ranks as one of the fastest growing healthcare technology companies in United States. Singh believes strongly in self-motivation and creative innovation and these attributes have become the cornerstone of Edifecs positive and highly collaborative working environment.
In 2013, Singh received a prestigious invitation from The White House to speak to a select group of leading American-Sikh entrepreneurs. His accolades include the 2010 WEDI Leadership in Technology Award, the 2011 Ernst & Young Entrepreneur of the Year Award and the Puget Sound Business Journal’s 40-Under-40 for his outstanding leadership.
In 2014, Singh decided to expand his dream to achieve a holistic ecosystem of health innovations. RoundGlass was that extension. A socially-conscious global firm, RoundGlass spurs innovation and disruption in digital health and wellness. The organization’s core mission is to build a vibrant ecosystem of innovation through investment, knowledge sharing and technology. It also funds and mentors the entrepreneurs who are driving the future of digital health.
RoundGlass fuels collaboration between business leaders, academia, technologists and entrepreneurs. With its initial focus in India and the US, the company plans to expand its footprint globally in the future.
Singh is highly sought-after mentor among his peers and professional colleagues. He also serves as an educator for several industry associations. He has testified to the National Committee on Vital and Health Statistics, and has hosted state congressional representatives at the Edifecs headquarters to discuss administrative simplification.
Singh’s non-profit foundation, SabTera, is a living manifestation of his dedication to wellness and philanthropy. SabTera, launched its pilot project in India with an educational programme for children from underprivileged socio-economic backgrounds and communities. The aim of the program is to cultivate an environment that is conducive to joyful learning and creativity. SabTera empowers these students to overcome their circumstances by giving them the knowledge and tools they need to build a positive future.
Psychologist and award-winning author Susan Pinker is a seasoned observer of modern communication and social contact. Whether writing on gender differences, as in The Sexual Paradox, or on why face-to-face contact should be a priority, as in The Village Effect, Pinker’s evidence-based insights help us improve the ways we work, play, and relate to each other.
Susan Pinker, a psychologist, journalist, and best-selling author, writes about the social sciences with sophistication and lucidity. Her first book, The Sexual Paradox, is an engrossing read on the differences between the sexes: how they think, how they behave, what will sway them, and how each defines success. The book caused an international sensation, was published in 17 countries, and received the prestigious William James Book Award given by the American Psychological Association.
Her latest book, The Village Effect: How Face-to-Face Contact Can Make Us Healthier, Happier, and Smarter, is about the impact of face-to-face contact on health, lifespan, education, romance, and business (ideas she shared on the TED2017 mainstage). Publishers Weekly calls it “a hopeful, warm guide to living more intimately in an disconnected era.” Charles Duhigg wrote, “Susan Pinker’s delightful book shows why face-to-face interaction at home, school and work makes us healthier, smarter and most successful.”
Pinker currently writes about fresh finds in behavioral science for The Wall Street Journal’s Mind and Matter column. She wrote The Business Brain and Problem Solving columns for The Globe and Mail, which applied the latest evidence from the fields of neuroscience, behavioral economics, and sports psychology to the world of business. She regularly writes opinions and feature articles on psychology, public policy, education, behavioral economics, and business for the international press. Her ideas have been featured in The Newy York Times, The Wall Street Journal, The Economist, Fast Company, MacLean’s, The Times of London, Psychology Today, and Oprah Magazine. She spent over two decades in clinical practice and taught Educational Psychology at McGill University.
Kevin Caldwell is Co-Founder & CEO of Ossium Health, where he leads the team that is building the world’s first bank of life saving, on-demand bone marrow stem cells for transplant. This new source of bone marrow will enable immunosuppresion-free organ transplants, improved blood cancer therapies, rapid response radiation injury treatment and other novel uses.
Prior to founding Ossium, Kevin worked as an Engagement Manager at McKinsey’s San Francisco office where he served clients in the technology sector. Before McKinsey, Kevin served as a Senior Investment Associate at Bridgewater Associates where he did quantitative research for the firm’s global macro investment strategy. Kevin holds degrees from MIT and Harvard Law School.
When he’s not building companies to tackle the world’s problems, Kevin enjoys science fiction novels, hang gliding, and exploring the beautiful Northern California coast.
Dr. Chunharas is presently, the president of National Health Foundation, a Thai NGO, working on knowledge-based health policy and system development. He graduated in 1977 with a degree in medicine from Mahidol University Thailand and became Board Certified in preventive medicine with a Masters Degree in Public Health from The Royal Tropical Institute, Netherland. He has extensive work experiences from being a physician and director in community hospitals in rural Thailand to international health and from health planning to being deputy minister of health.
Dr. Chunharas’s specific areas of interest and experiences include health policy and system research, health insurance system, research ethics, information system, human resource development, knowledge management, and learning organization. He has authored articles and book chapters on these topics in Thai as well as English. He is the founding Director of the Health Systems Research Institute, which provided crucial technical support in designing the Thai Universal Coverage Scheme. He also led the team to propose research system reform for Thailand which has served as foundation work for subsequent proposals and plans to reform Thai research system over the last 10 years. He is also the founding secretary general of Thai Gerontology Research Institute (TGRI), a non-governmental research promotion and knowledge management for policy towards aging society.
He works with various organizations in health policy and system development both at home and abroad. He has worked as evaluator for Swedish support to MCH in Laos and Swiss support to Cambodia and in earlier TRF evaluation. He also acts as a consultant and resource person in various international meetings and programmes. He has served in WHO ACHR of 2 regional offices as well as at HQ level and has been a board member of international research organizations such as COHRED and AHPSR/WHO and has been consultant to WHO and UNICEF along with being an expert resource person of ministerial leadership programme of Harvard Kennedy School and School of Public Health. Last but not the least, Dr. Chunharas has been invited to be Menschel Senior Leadership Fellow at HSPH in 2017.
Laksono Trisnantoro is a Professor in Health Policy and Administration and Head of newly established Department of Health Policy and Management at Faculty of Medicine Universitas Gadjah Mada, Indonesia. He obtained his MD from Universitas Gadjah Mada (UGM) in 1987, Master of Science (MSc) in Health Economics from the Department of Economics University of York, UK, and his Ph.D from London School of Hygiene and Tropical Medicine in 1993. He is currently the Chief Editor of Indonesian Journal of Indonesian Health Policy. His main interest is in health policy and administration, especially health service decentralization, equity, and disaster management. He has served as consultant for Minister of Health and local government for many years.
Laksono’s career is more in academic stream, not in deanship or rectorate. Laksono has established various units: Graduate program in Hospital Management (1992, at the age of 29 years), Center for Health Policy and Management (1998, at the age of 37), and Academic Department (Health Policy and Management, 2016, at 54 years) during 30 years of academic life. He also revitalized the PhD program as Vice Director and served in this position under 3 directors for more than 15 years. He led various far-flung projects which emphasized equity in the objectives. Thousands of human resources were deployed to various remote areas under Laksono project directorship. This experience put into some parts of Medical Education Acts in 2013. Laksono’s interest for supporting the remote areas came into a new frontier when he introduced a web-based Knowledge Project in 2016.
Navi Radjou is an innovation and leadership thinker and advisor in Silicon Valley. A Fellow at Cambridge University's Judge Business School, he has served on World Economic Forum's Global Future Council on Entrepreneurship and Innovation. Previously, he was a Vice President at Forrester Research in Boston and San Francisco. A TED Speaker, he won the 2013 Thinkers 50 Innovation Award. He is the co-author of Jugaad Innovation(2012), From Smart To Wise (2013) and Frugal Innovation (2015), published by The Economist. His next book, Conscious Society: Reinventing How We Consume, Work, Relate and Live, will be published in 2019. Born and raised in Pondicherry, India, he holds French-American dual citizenship. He studied at Ecole Centrale Paris and Yale School of Management.
Hover over the Speaker's photo to view their bio data. Updated as of 19 July 2018 subject to changes at the Organiser's discretion.
As Prime Minister of Greece, Mr. Papandreou applied a series of structural reforms to modernize his country and was named as as one of Top 100 Global Thinkers by Foreign Policy Magazine.
In 2010, Mr. Liao founded WeDoctor Group - a leading healthcare solutions platform that has connected over 2,400 hospitals, more than 120 million platform users, and over 220,000 doctors across China.
A clinician and microbiologist by training, Dr. Piot co-discovered the Ebola virus in Zaire in 1976, and subsequently led pioneering research on HIV/AIDS, women’s health and infectious diseases in Africa.
Dr. Jha's research endeavors focus on improving the quality and costs of health care systems with a specialized emphasis on the impact of policies and ways to improve health care systems.
Robyn's focus is on restoring the health of families in order to address the burden that disease in placing on our economy. Her work addresses the needs of children who have allergies, autism, ADHD and asthma.
As a medical geneticist, Dr. Green conducts empirical research on the medical, behavioral and economic outcomes around the implementation of genomic medicine.
Dr. Mao was born and raised in a family medical tradition that has spanned 38 generations. He rst began his studies in Chinese medicine with his father, and has since been a bestselling author, and an expert on longevity medicine.
Dr. Suhas is one of the most academically accomplished Ayurvedic physicians in the US and has popularized Ayurvedic Medicine by setting up clinics, offering courses, and providing consultations around the world.
Marc Koska is the inventor of the K1 Auto-Disable syringe and a highly regarded advocate for needle safety in both immunisation and therapeutic sectors.
Colin Milner is a leading authority on the health and well-being of the older adult, and has been recognized by the World Economic Forum as one of "the most innovative and in uential minds" in the world on aging-related topics.
Meena is one of India’s foremost business leaders and heads India's leading consumer healthcare brand that operates across primary care, chronic disease management, elder care, and post-operative care.
Dr. Mohr is a HealthTech executive with over 20 years of experience and evaluates new technologies for the next generation of computer aided surgical platforms at Intuitive Surgical (a global leader in robotic-assisted minimally invasive surgery).
John is an accomplished entrepreneur with the mission to bring advanced technologies to patients with unmet or poorly met medical needs.
As an entrepreneur and a software and industrial engineering expert, Singh is on a mission to build a vibrant health ecosystem of innovation through investment, knowledge sharing and technology.
Susan is a psychologist, journalist, and best-selling author who writes about psychology, public policy, and the impact of face-to-face contact on health, lifespan, education, and business.
Kevin is building the world’s first bank of life saving, on-demand bone marrow stem cells for transplant that will enable immunosuppresion-free organ transplants, improved blood cancer therapies and other novel uses.
Dr. Chunharas has extensive work experiences from being a physician and director in community hospitals in rural Thailand to international health and from health planning to being deputy minister of health.
In addition to being a professor of Health Policy, Prof. Trisnantoro is also a consultant for Indonesia's Minister of Health and local government for many years. His main interest is in health policy and administration, especially health service decentralization, equity, and disaster management.
Navi is an innovation and leadership thinker, an author, a TED Speaker, and the winner of 2013 Thinkers 50 Innovation Award.
Hover over the Entrepreneurs's photo to view their bio data. Updated as of 19 July 2018 subject to changes at the Organiser's discretion.
StoryMD is a platform that interprets, stores and explains an individual's health status and facilitates every user’s ability to visually understand the story of their body.
Cocoon Cam is a Silicon Valley-based technology company using computer vision and AI for remote non-contact health monitoring.
Jana Care enables bio-marker assisted chronic disease management through a smartphone based diagnostics platform.
NephroPlus is India’s largest and world's 8th largest dialysis network of 140 centers in 85 cities across 18 states.
Dovetail Lab aims to harness the power and security of blockchain and distributed ledger technology to improve information governance and provide flexible information sharing between practitioners and their patients.
ikioo is leading the way to a shift from a “disease-centric” to a “health-centric” healthcare system through its on-the-go intelligent personal health companion powered by Artificial Intelligence platform.
Centrillion provides top-of-the-line molecular and genomics services including next generation sequencing, droplet digital PCR, and bioinformatics.
Forus Health is working on the mission of eradicating preventable blindness using technology in the the ophthalmology space.
BURL Concepts is a San Diego-based medical device start-up that manufactures portable ultrasound device to detect strokes in the field.
access.mobile is an intelligent mobile engagement platform that improves patient care while reducing costs for healthcare organizations.
CXA brings evidence-based wellness into the workplace to improve employee health and control healthcare costs.
Coeo Labs is an Indian medical device company solving unmet clinical needs in the field of emergency and critical care.